Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants.
暂无分享,去创建一个
Naftali Raz | Cheryl L. Dahle | Yiqin Yang | N. Raz | S. Land | Yiqin Yang | Cheryl L Dahle | Susan Land
[1] A D Roses,et al. Apolipoprotein E and Alzheimer's Disease A Rapidly Expanding Field with Medical and Epidemiological Consequences , 1996, Annals of the New York Academy of Sciences.
[2] T. Schmitz,et al. Cytokines and Myelination in the Central Nervous System , 2008, TheScientificWorldJournal.
[3] W. Jagust,et al. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype , 2008, Neurobiology of Aging.
[4] Faith M. Gunning-Dixon,et al. Aging of cerebral white matter: a review of MRI findings , 2009, International journal of geriatric psychiatry.
[5] H Lechner,et al. White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. , 1988, Stroke.
[6] J. Wade,et al. Vascular risk factors and leuko-araiosis. , 1987, Archives of neurology.
[7] J. Grassi,et al. Secretion of interleukin‐1β by astrocytes mediates endothelin‐1 and tumour necrosis factor‐α effects on human brain microvascular endothelial cell permeability , 2003 .
[8] C. Sing,et al. Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.
[9] F. Fazekas,et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. , 1997, Stroke.
[10] P. Sachdev,et al. Sex differences in the causes and consequences of white matter hyperintensities , 2009, Neurobiology of Aging.
[11] Carolyn Katrinchak,et al. Clinical implications of C‐reactive protein as a predictor of vascular risk , 2007, Journal of the American Academy of Nurse Practitioners.
[12] Antonella Plaia,et al. Association between the interleukin-1β polymorphisms and Alzheimer's disease: A systematic review and meta-analysis , 2008, Brain Research Reviews.
[13] M. Goto. Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? , 2008, Bioscience trends.
[14] C. DeCarli,et al. Inflammatory Biomarkers of Vascular Risk as Correlates of Leukoariosis , 2009, Stroke.
[15] N. Prins,et al. Neuroanatomical localisation and clinical correlates of white matter lesions in the elderly , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[16] S. Brod. Unregulated inflammation shortens human functional longevity , 2000, Inflammation Research.
[17] H. Cohen,et al. Cytokines and Cognition—The Case for A Head‐to‐Toe Inflammatory Paradigm , 2002, Journal of the American Geriatrics Society.
[18] Bernhard T. Baune,et al. Association Between Cytokines and Cerebral MRI Changes in the Aging Brain , 2009, Journal of geriatric psychiatry and neurology.
[19] Y. Itoyama,et al. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. , 1995, Stroke.
[20] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[21] André G. Uitterlinden,et al. Genetic variation in homocysteine metabolism, cognition, and white matter lesions , 2010, Neurobiology of Aging.
[22] N. Rothwell,et al. Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Green,et al. A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.
[24] C. Franceschi,et al. Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .
[25] M. Orellana,et al. Homocysteine and Essential Hypertension , 2003, Journal of clinical pharmacology.
[26] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[27] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[28] P. Scheltens,et al. Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old , 2010, Neurology.
[29] Irving Kushner,et al. C-reactive Protein* , 2004, Journal of Biological Chemistry.
[30] P. Lazzerini,et al. Hyperhomocysteinemia, inflammation and autoimmunity. , 2007, Autoimmunity reviews.
[31] C. McCollum,et al. Deletion/Insertion Polymorphism of the Angiotensin‐Converting Enzyme Gene and White Matter Hyperintensities in Dementia: A Pilot Study , 2006, Journal of the American Geriatrics Society.
[32] Ulman Lindenberger,et al. White matter deterioration in 15 months: latent growth curve models in healthy adults , 2012, Neurobiology of Aging.
[33] C. Sudlow,et al. Genetic Determinants of White Matter Hyperintensities on Brain Scans: A Systematic Assessment of 19 Candidate Gene Polymorphisms in 46 Studies in 19 000 Subjects , 2009, Stroke.
[34] Sanja Stankovic,et al. Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors , 2010, Critical reviews in clinical laboratory sciences.
[35] Faith M. Gunning-Dixon,et al. Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study , 2003, Neuropsychologia.
[36] H. Aizenstein,et al. Regional grey matter shrinks in hypertensive individuals despite successful lowering of blood pressure , 2011, Journal of Human Hypertension.
[37] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[38] Wang Min,et al. Leuko araiosis , 2006 .
[39] S. Marenco,et al. Regional Cerebral Blood Flow in Chronic Hypertension: A Correlative Study , 1993, Stroke.
[40] Nicolas Cherbuin,et al. Neuroimaging and APOE Genotype: A Systematic Qualitative Review , 2007, Dementia and Geriatric Cognitive Disorders.
[41] Zhijun Zhang,et al. The D-allele of ACE insertion/deletion polymorphism is associated with regional white matter volume changes and cognitive impairment in remitted geriatric depression , 2010, Neuroscience Letters.
[42] Michael H Lev,et al. Regional Ischemic Vulnerability of the Brain to Hypoperfusion: The Need for Location Specific Computed Tomography Perfusion Thresholds in Acute Stroke Patients , 2011, Stroke.
[43] Cheryl L. Dahle,et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. , 2005, Cerebral cortex.
[44] L. Radloff. The CES-D Scale , 1977 .
[45] J. Hall,et al. The renin-angiotensin system: renal actions and blood pressure regulation. , 1991, Comprehensive therapy.
[46] J. Felblinger,et al. Association Study of Gene Polymorphisms Involved in Vascular Alterations in Elderly Hypertensives with Subjective Memory Complaints , 2010, Dementia and Geriatric Cognitive Disorders.
[47] J. H. Steiger. Tests for comparing elements of a correlation matrix. , 1980 .
[48] L. Fañanás,et al. Gray matter deficits in bipolar disorder are associated with genetic variability at interleukin‐1 beta gene (2q13) , 2008, Genes, brain, and behavior.
[49] A. Pfefferbaum,et al. Selective age-related degradation of anterior callosal fiber bundles quantified in vivo with fiber tracking. , 2006, Cerebral cortex.
[50] A. de la Sierra,et al. Renin-Angiotensin System Genetic Polymorphisms and Cerebral White Matter Lesions in Essential Hypertension , 2002, Hypertension.
[51] H. Markus. Genes, endothelial function and cerebral small vessel disease in man , 2008, Experimental physiology.
[52] Karen M Rodrigue,et al. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. , 2003, Behavioral neuroscience.
[53] Yaakov Stern,et al. Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging , 2009, Psychiatry Research: Neuroimaging.
[54] Jing He,et al. Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. , 2010, Archives of neurology.
[55] V. Thijs,et al. Association of Apolipoprotein E ϵ2 With White Matter Disease but Not With Microbleeds , 2007 .
[56] S. Black,et al. Periventricular and subcortical hyperintensities on magnetic resonance imaging. 'Rims, caps, and unidentified bright objects'. , 1988, Archives of neurology.
[57] P. Guarino,et al. Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[58] R. C. Oldfield. The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.
[59] Frederik Barkhof,et al. Progression of White Matter Hyperintensities and Incidence of New Lacunes Over a 3-Year Period: The Leukoaraiosis and Disability Study , 2008, Stroke.
[60] Manuel Desco,et al. Ventricular enlargement in schizophrenia is associated with a genetic polymorphism at the interleukin-1 receptor antagonist gene , 2005, NeuroImage.
[61] T. Kemper,et al. Neuroanatomical and neuropathological changes during aging and dementia. , 1994 .
[62] A. Song,et al. Cerebral White Matter Integrity and Cognitive Aging: Contributions from Diffusion Tensor Imaging , 2009, Neuropsychology Review.
[63] M. Hurme,et al. IL‐1 receptor antagonist (IL‐1Ra) plasma levels are co‐ordinately regulated by both IL‐1Ra and IL‐1β genes , 1998 .
[64] J. Kril,et al. Neuropathologic correlates of white matter hyperintensities , 2008, Neurology.
[65] B. Rossier,et al. Physiological and pathophysiological role of the epithelial sodium channel in the control of blood pressure. , 1996, Kidney & blood pressure research.
[66] Karen M Rodrigue,et al. Vascular health and longitudinal changes in brain and cognition in middle-aged and older adults. , 2007, Neuropsychology.
[67] M. Fornage,et al. Genomewide association studies of stroke. , 2009, The New England journal of medicine.
[68] B L Miller,et al. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. , 1998, Stroke.
[69] Mark D'Esposito,et al. Imaging the aging brain , 2009 .
[70] Ihab Hajjar,et al. Hypertension and Cerebral Vasoreactivity: A Continuous Arterial Spin Labeling Magnetic Resonance Imaging Study , 2010, Hypertension.
[71] M. Province,et al. Association of Common C-Reactive Protein (CRP) Gene Polymorphisms With Baseline Plasma CRP Levels and Fenofibrate Response , 2008, Diabetes Care.
[72] A. Peters. The effects of normal aging on myelin and nerve fibers: A review , 2002, Journal of neurocytology.
[73] J. Gabrieli,et al. Insights into the ageing mind: a view from cognitive neuroscience , 2004, Nature Reviews Neuroscience.
[74] A. Hingorani,et al. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. , 2004, Archives of neurology.
[75] Silvia Kochen,et al. Association study between interleukin 1β gene and epileptic disorders: a HuGe review and meta-analysis , 2008, Genetics in Medicine.
[76] G. Bartzokis,et al. In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia , 2009, Schizophrenia Research.
[77] R. P. Stroemer,et al. Cortical Protection by Localized Striatal Injection of IL-1ra Following Cerebral Ischemia in the Rat , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[78] D. Harvey,et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD , 2006, Neurology.
[79] A Hofman,et al. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study , 2001, Journal of neurology, neurosurgery, and psychiatry.
[80] Jennifer G. Robinson,et al. Relationship of Hypertension, Blood Pressure, and Blood Pressure Control With White Matter Abnormalities in the Women’s Health Initiative Memory Study (WHIMS)—MRI Trial , 2010, Journal of clinical hypertension.
[81] D. Head,et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. , 1997, Cerebral cortex.
[82] S. Resnick,et al. The Impact of Magnetic Resonance Imaging-Detected White Matter Hyperintensities on Longitudinal Changes in Regional Cerebral Blood Flow , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[83] L. Pantoni,et al. Cognitive Impairment and Cellular/Vascular Changes in the Cerebral White Matter a , 1997, Annals of the New York Academy of Sciences.
[84] Caleb E. Finch,et al. Evolution of the human lifespan and diseases of aging: Roles of infection, inflammation, and nutrition , 2009, Proceedings of the National Academy of Sciences.
[85] G. Wilcock,et al. Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population , 1998, International journal of geriatric psychiatry.
[86] O B Paulson,et al. Cerebral blood flow in untreated and treated hypertension. , 1995, The Netherlands journal of medicine.
[87] Klaus Berger,et al. CRP Gene Haplotypes, Serum CRP, and Cerebral Small-Vessel Disease: The Rotterdam Scan Study and the MEMO Study , 2007, Stroke.
[88] J. Haxby,et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.
[89] E Rostrup,et al. Cerebral Perfusion and Cerebrovascular Reactivity Are Reduced in White Matter Hyperintensities , 2002, Stroke.
[90] A. Kondacs,et al. Specific APO E genotypes in combination with the ACE D/D or MTHFR 677TT mutation yield an independent genetic risk of leukoaraiosis , 2004, Acta neurologica Scandinavica.
[91] Peter Kochunov,et al. Whole Brain and Regional Hyperintense White Matter Volume and Blood Pressure: Overlap of Genetic Loci Produced by Bivariate, Whole-Genome Linkage Analyses , 2010, Stroke.
[92] W. Brown,et al. Review: Cerebral microvascular pathology in ageing and neurodegeneration , 2011, Neuropathology and applied neurobiology.
[93] F. Cambien. The angiotensin‐converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction , 1994, Clinical genetics.
[94] N. Rothwell. Cytokines ‐ killers in the brain? , 1999 .
[95] D. Tate,et al. Role of white matter lesions, cerebral atrophy, and APOE on cognition in older persons with and without dementia: the Cache County, Utah, study of memory and aging. , 2003, Neuropsychology.
[96] Bruce M Psaty,et al. Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study , 2008, Stroke.
[97] R. Heimburger,et al. Impaired cerebral functions in essential hypertension. , 1951, The American journal of psychiatry.
[98] Janice E. Knoefel,et al. Clinical neurology of aging , 1985 .
[99] J. Fleiss,et al. Intraclass correlations: uses in assessing rater reliability. , 1979, Psychological bulletin.
[100] A Hofman,et al. C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study , 2005, Circulation.
[101] B. Israelsson,et al. Plasma homocysteine and methionine tolerance in early-onset vascular disease. , 1989, Haemostasis.
[102] Thomas E. Nichols,et al. Lesion probability maps of white matter hyperintensities in elderly individuals , 2006, Journal of Neurology.
[103] Charles DeCarli,et al. Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.
[104] A. Słowik,et al. Interleukin 1 Beta Polymorphism (–511) and Risk of Stroke due to Small Vessel Disease , 2005, Cerebrovascular Diseases.
[105] Eric Vicaut,et al. Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.